This training program is a collaborative effort between the New York State Education Department and the New York State Department of Health utilizing

Size: px
Start display at page:

Download "This training program is a collaborative effort between the New York State Education Department and the New York State Department of Health utilizing"

Transcription

1 Heroin addiction and prescription opioid abuse are persistent national problems that reach deep into communities across New York and heavily affect young adults. NYS has been awarded $8.1 million in federal funds to help prevent heroin use, prescription drug abuse, and opioid overdose among adolescents and young adults across the State, while also increasing awareness about the dangers of these drugs. The Combat Heroin campaign was launched in September 2014 to educate New Yorkers about the risks of heroin and prescription opioid use, the warning signs of addiction, and provide resources to help. Emergency medical personnel, health care professionals, and patients are being trained in the use of the opioid antagonist naloxone to reverse and prevent opioid overdose. Schools and school districts are now permitted to become Opioid Training Programs and train volunteer personnel. This program will provide education on opioids and the current epidemic as well as training for school personnel on administering naloxone for opioid overdose. Resource: Opioid Overdose Prevention Programs Providing Naloxone to Laypersons United States, 2014 Morbidity and Mortality Weekly Report (MMWR)-June 19,2015 / 64(23);

2 This training program is a collaborative effort between the New York State Education Department and the New York State Department of Health utilizing resources provided by other collaborative partners noted in the next slide. Completion of this training, 100% accuracy on the post-test and the skills check for administering naloxone will allow school personnel to administer life-saving medication naloxone in school. Although the certificate of completion is valid for two years, NYSED strongly encourages review annually to ensure both understanding and skills in opioid overdose response that are current and timely. Additional information on training and implementing an opioid overdose prevention program is available on the NYSED Opioid Overdose Prevention Guidance Document available on the NYSED website. In addition, useful resources you can view and print can be found in the upper right corner of this webinar. 2

3 As part of a coordinated State effort, the NYS Department of Health, the NYS Office of Alcohol Substance Abuse Services (OASAS) and the Harm Reduction Coalition have been working collaboratively with the NYS Education Department on statewide communications and training for schools in combating heroin and supporting opioid prevention education including supporting schools in the ongoing modernization of local level health education curriculum, development of a school/community toolkit, and additional resources in this webinar. We would like to gratefully acknowledge the wealth of resources shared by these collaborating agencies used in the creation of this presentation. 3

4 The goal of this presentation is to provide school responders with training to recognize a suspected opioid overdoses, and to take appropriate action by administering naloxone when needed. The objectives are listed on this slide. A Terms to Know resource sheet is located in the resource tab above. Click it at any time to review a term which is unfamiliar to you. 4

5 Heroin and prescription drug misuse occurs in all social, economic, geographic and cultural groups. Overdose among those who use illicit opioids such as heroin and among those who misuse medications such as oxycodone, hydrocodone, and morphine is rising, largely due to increased use of prescribed opioids for treatment of pain. Children, as young as 12, are using prescription drugs to get high. Prescription drugs are easier to access because they can be taken from a home medicine cabinet and young people may believe they are safer than illicit drugs because they are manufactured by a pharmaceutical company. According to the Centers for Disease Control and Prevention (CDC), an average of 120 people die every day from an accidental or intentional drug overdose in the U.S. Roughly 80% of these deaths were accidental, and more than 16,000 involved prescription opioids, compared to 8,260 attributed to heroin. Evidence indicates some people who use prescription opioids have switched to heroin in recent years as it is often cheaper and easier to get. This has caused an increase in heroin deaths. In 2014, there were more than 118,000 admissions into New York State-certified treatment programs for heroin and prescription opioid abuse a 17.8 % increase over The largest increase in opioid admissions during that time was patients ages 18 to 34. Resource: Substance Abuse and Mental Health Services Administration. SAMHSA Opioid Overdose Prevention Toolkit. HHS Publication No. (SMA) Rockville, MD: Substance Abuse and Mental Health Services Administration, page 4. accessed 6/29/15 5

6 This chart shows the total number of US overdose deaths involving heroin. From 2001 to 2013 there was a 5-fold increase in the total number of deaths. Resource: National Overdose Deaths Number of Deaths from Heroin, National Institute on Drug Abuse (NIH), Revised February

7 This chart shows the total number of US overdose deaths involving opioid pain relievers. From 2001 to 2013 there was a 3-fold increase in the total number of deaths. Source: National Overdose Deaths Number of Deaths from Rx Opioid Pain Relievers, National Institute on Drug Abuse (NIH), Revised February

8 As seen in this infographic, heroin use is part of a larger substance abuse problem. Resource: National Survey on Drug Use and Health (NSDUH),

9 Federal, state and local government as well as private organizations are attacking this issue from many angles. The main goals are shared on this slide. Opioid use and overdose is a community problem which will require a community solution. Resource: CDC Vital Signs July

10 Most overdoses are not instantaneous and are preventable, especially if witnesses have had appropriate training and are prepared to respond in a safe and effective manner. In school, staff may find the victim or be the first person on the scene. The chance of surviving an overdose, like that of surviving a heart attack, depends greatly on how fast one receives medical assistance. With training on risk factors, signs of overdose and the appropriate responses including contacting EMS, providing resuscitation and/or administration of naloxone, volunteer school personnel are well-positioned to assist in an opioid emergency. School staff are also in a positon to educate students on the dangers of prescription drug misuse and refer concerns regarding students to appropriate school administrators or assistance teams. Resource: Sharon Stancliff, MD*, Steven Kipnis, MD, FACP, Fasam, Robert Killar, CASAC *This workbook is adapted from a presentation by Dr. Sharon Stancliff s program Get the SKOOP: Skills and Knowledge on Overdose Prevention. Dr. Stancliff is the Medical Director of the Harm Reduction Coalition in New York City. 10

11 New laws in NYS now allow schools to institute Opioid Overdose Prevention Programs and train volunteer school personnel to administer a life-saving medication called naloxone. The applicable laws and regulations will be reviewed in the next slides. It is the responsibility of licensed individuals to understand their scope of practice and the school or school district to create district policy and procedures which align with these laws and guidelines to provide a framework for implementing any opioid overdose program. 11

12 On April 1, 2006, NYS enacted a public health law called the: Community Access to Naloxone Law. Public Health Law 3309 states that: Use of an opioid antagonist pursuant to this section shall be considered first aid or emergency treatment for the purpose of any statute relating to liability This law allows trained non-medical, unlicensed persons to use naloxone on individuals suspected of having experienced an opioid overdose. Another law allows a physician or a nurse practitioner to issue nonpatient specific orders for the administration of naloxone by registered nurses. Districts may operate opioid overdose prevention programs and share access to naloxone kits. Resource: 1 10 NYCRR (a)(5)(v). Section Opioid Overdose Prevention Programs - Effective Date: 05/06/ d7/7cd10ccf2f32a94a ea1e9 New York State's Opioid Overdose Prevention Programs 12

13 Chapter 57 of the Laws of 2015 added section 922 to Education Law which permits NYS school districts, BOCES, charter schools, non-public elementary and/or secondary schools to provide and maintain opioid antagonists on site in each instructional facility to ensure emergency access for any student or school personnel having opioid overdose symptoms, whether or not they have a previous known history of opioid abuse. Schools choosing to participate as an opioid antagonist recipient may permit volunteer employees to be trained by a program approved under Public Health Law section 3309 to administer an opioid antagonist in the event of an emergency. 13

14 A school or school district must create policies and procedures to provide guidance on opioid overdose prevention and response. All policies should be consistent with the laws and regulations of the State of New York. They should be signed and dated and reviewed at least annually to ensure they continue to meet the needs of the program and are consistent with recommended best practice. Use of naloxone should be included in district emergency response procedures. There should be protocols in place to monitor the inventory, storage, use and reporting of naloxone administration and overdose reversals. New York State NYSDOH has sample guidance for developing policies and procedures for registered opioid overdose prevention programs on their Opioid Prevention webpage. While specifically written for DOH registered programs, these may also be helpful resources for schools to develop their policies in conjunction with district counsel. Resources: NYSDOH Opioid Overdose Prevention Guidelines for Policy and Procedures, March 21, prevention/programs/guidelines/docs/policies_and_procedures.pdf NYS Harm Reduction Webpage prevention/programs/guidelines/docs/policies_and_procedures.pdf 14

15 Part V of Chapter 57 of the Laws of 2015 added a new paragraph (f), to both subdivision 6 of sections 6527 (Article 131 Medicine) and subdivision 4 of 6909 (Article 139 Nursing) of the NYS Education Law, permitting registered professional nurses to execute non-patient specific orders prescribed by a NYS licensed physician or a certified nurse practitioner to administer urgent or emergency treatment of opioid related overdose or suspected opioid related overdose or suspected opioid related overdose. This addition places administration of non-patient specific naloxone within the scope and practice of the registered professional nurse. 15

16 This flow chart details how Opioid Overdose antagonists (naloxone) can be administered in the school settings. Additional information implementing an opioid overdose prevention program is available in the NYSED Opioid Overdose Prevention Guidance Document available on the NYSED website. The next slide provides the requirements of how a school or school district may register as a NYSDOH registered Opioid Overdose Prevention Program. This resource chart is available on the NYSSHSC website and in the upper right corner of this webinar. Resources: NYS DOH Opioid Overdose Regulations Q & A Title 10 of New York Codes, Roles and Regulations Department of Health, Chapter II Administrative Rules and Regulations, Subchapter K Controlled Substances, Part 80 Rules and Regulations on Controlled Substances, Section Opioid Overdose Prevention Programs NYSDOH Opioid Overdose Prevention: Registration Form: 16

17 If a school district chooses to register and become a NYSDOH Opioid Overdose Prevention Program, the school district or provider must complete the requirements on this slide. Registration forms are available on the Opioid Overdose Prevention page on the NYSDOH website. Resource: NYSDOH Opioid Overdose Prevention Program sheet.htm 17

18 10 NYCRR , requires that each opioid overdose prevention program have a program director. They have overall responsibility for managing the program and for being the primary liaison with the NYSDOH either directly or through a designee. Their responsibilities include those listed on this slide. This role may be filled by the district superintendent, director or CEO of a nonpublic school, or their designee. Designee options could include the principal or school nurse if employed. Because suspected drug overdoses may result in a situation where the student does not need naloxone, but does need follow up care of referral, it is important that clear protocols are in place to provide guidance and direct personnel response. Resources: NYS DOH Opioid Overdose Regulations Title 10 of New York Codes, Roles and Regulations Department of Health, Chapter II Administrative Rules and Regulations, Subchapter K Controlled Substances, Part 80 Rules and Regulations on Controlled Substances, Section Opioid Overdose Prevention Programs d7/7cd10ccf2f32a94a ea1e9 18

19 Clinical directors are the primary personnel designated in a program s registration for prescribing naloxone to be administered by an individual or an identifiable pool of trained volunteers such as school personnel. In addition to prescribing and/or dispensing naloxone, their specific responsibilities include those listed on this slide. Clinical directors may be a NYS licensed physician or NP. While prescribers do not need to be present when responders are trained, procedures need to be in place to ensure that naloxone is given under either a patient specific and/or a non patient specific prescription and that all responders have been trained in overdose recognition and response. Shared access to naloxone kits which include the atomizer and medication is sometimes referred to as communal access. In a school district this role would typically be filled by the school medical director, which in NYS must be a physician or nurse practitioner. Resource: NYS DOH Opioid Overdose Regulations Q & A Title 10 of New York Codes, Roles and Regulations Department of Health, Chapter II Administrative Rules and Regulations, Subchapter K Controlled Substances, Part 80 Rules and Regulations on Controlled Substances, Section Opioid Overdose Prevention Programs d7/7cd10ccf2f32a94a ea1e9 19

20 The school nurse is the on-site health expert and may be designated in writing to complete the post-training skills check for non-medical, unlicensed school personnel at the request of the clinical director or (school medical director). School nurses also play a key role in planning and responding as part of the school s emergency team. School district emergency response plans should include protocols for responding to opioid overdose, should be developed in conjunction with the medical director, and include provisions for ensuring AED and a responder trained in its use are available during onsite school and school sponsored activities. School nurses can also support prevention efforts by reinforcing risk factors for opioid overdose when appropriate during health interactions with students. The NYSDOH and OASAS created the resource on this slide to help school nurses be proactive in preventing young people s non medical use of prescription drugs. It contains multiple links school nurses can use to educate themselves, students and parents on prescription drug abuse, including two National Association of School Nurse Programs. It is available on the Heroin and Opioid page of the NYSSHSC website. Resource: Joint Advisory Letter for School Nurses: Non-Medical Use of Prescription Drugs by Young People - New York State OASAS and New York State DOH 20

21 School personnel who wish to voluntarily become trained opioid overdose responders must complete an initial Opioid Overdose Prevention training program, post-test and skills check. To maintain their status as a trained school responder, they must complete training every 2 years, however the NYSED strongly recommends annual refresher training to maintain skills. School districts may require training annually if included in the district policy. It is important that trained school responders contact emergency medical services (EMS) when encountering a victim of a suspected drug overdose and inform responding EMS if an opioid antagonist has been used. School trained overdose responders must report all naloxone administrations for suspected drug overdose to the opioid overdose prevention program director or their designee for review. Maintaining accurate inventory records is important in assuring that naloxone is available and maintained in accordance with NYSDOH regulations. 21

22 Opioids are any drugs that are derived from or are similar to opium. They can be swallowed, smoked, snorted or injected. They include illegal drugs such as heroin, as well as prescription medications used to treat pain. Heroin converts to morphine once it is inside the body. It has a high potential for abuse causing severe psychological and physical dependence. Legal opioid pain medications can lead to moderate or severe dependence, and are often combined with other pain relieving medications by manufacturers, making them potential drugs of abuse. Common prescription opioids are listed on this slide. Opioids minimize the body s perception of pain and affect body systems responsible for regulating mood, breathing and blood pressure. In excessive amounts, opioids can suppress a person s urge to breathe. Resource: Substance Abuse and Mental Health Services Administration. SAMHSA Opioid Overdose Prevention Toolkit. HHS Publication No. (SMA) Rockville, MD: Substance Abuse and Mental Health Services Administration, page 4. accessed 6/21/

23 Dependency, withdrawal and addiction is reviewed on this slide. Resource: Combating the Opioid Overdose Epidemic -Public Safety Naloxone. 11/11/14 Michael W. Dailey, MD FACEP, Regional EMS Medical Director, Associate Professor of Emergency Medicine handout?from_action=save accessed 6/28/15 23

24 Opioid overdose happens when a toxic amount of an opioid alone or mixed with other opioid drugs or substances overwhelms the body s ability to handle it. Many opioid-related overdoses result from mixing prescription painkillers or heroin with benzodiazepines (benzos), cocaine or alcohol. Combined drugs can have a synergistic effect, which means that the effect of taking mixed drugs is greater than the effect of taking the drugs separately. In this case 1+1 does not equal 2, 1+1 = 10. Resource: Overdose Prevention & Reversal Training. Amu Ptah Riojas, MA, Harm Reduction Coordinator, Monique Wright, MEd, Harm Reduction Educator. NYC Department of Health and Mental Hygiene Bureau of Alcohol and Drug Use Prevention, Care and Treatment, 5/19/14 24

25 Opioid overdose can occur when someone misuses a prescription opioid or uses an illicit drug such as heroin. Also at risk is the person who takes opioid medications prescribed for someone else, or an individual who combines opioids prescribed or illicit with alcohol, certain other medications, and even some over-the-counter products that depress breathing, heart rate, and other functions of the central nervous system. Regular use of opioids leads to greater tolerance, i.e. more needed to achieve the same result. Overdose occurs often when people start using again following a period of not using (abstinence). Common situations leading to loss of tolerance include: incarceration, detox, Drug Free treatment, or self imposed breaks from use. Tolerance can decrease in as little as 72 hours. Using alone is a risk factor for opioid overdose death, because there is no one to intervene or call for assistance. Using multiple drugs at the same time as opioids is a significant risk factor. Resource: Substance Abuse and Mental Health Services Administration. SAMHSA Opioid Overdose Prevention Toolkit. HHS Publication No. (SMA) Rockville, MD: Substance Abuse and Mental Health Services Administration, page 4. accessed 6/21/

26 Anyone who uses opioids for long-term management of chronic pain is at risk for opioid overdose, as are persons who use heroin, which is cheap and highly addictive. Prescription drug abuse by youth is an increasing problem. Opioid overdose impacts all socio-economic groups and regions. Statistics in NYS show an alarming trend- drug overdoses are the leading cause of accidental death with people dying each day due to over dose. Resource: DCJS-Law Enforcement Naloxone Overview 26

27 Signs of an opiate overdose include some of those on this slide. Please be aware that other medical conditions can also cause these symptoms, and initiating emergency response to provide support is critical. Resources: New York State Department of Health Opioid Overdose Prevention Guidelines for Training Responders Addiction medicine educational series workbook NYS OSAS Photo: licensed under Creative Commons Attribution accessed 7/14/15 Medline Plus 27

28 Naloxone hydrochloride is an opioid antagonist medication which reverses the effects of opioids on the brain and other parts of the body causing sudden withdrawal and restoring breathing. It is available as a nasal spray and an injection. One injectable formulation of naloxone is Evzio auto-injector which was approved by the FDA in We will not be covering that product in this training. The small molecules in naloxone are easily absorbed through the nasal mucosa and eliminate the risk of needle stick injury to responders. It generally takes effect within 3-5 minutes. If you give naloxone to someone who is not experiencing an overdose, it will not hurt them. Naloxone has been used safely by medical professionals for more than 40 years and has only one function, which is to reverse the effects of opioids on the brain and respiratory system in order to prevent death. Resource: Harm Reduction Coalition: Guide to Developing & Managing Overdose Prevention & Take-Home Naloxone Projects 11/10/

29 Opioid receptors in the brain and other areas of the body and are where opioid molecules bind and cause responses in the body. During opioid overdose they cause breathing to stop. When breathing stops, the heart stops and circulation of blood to the brain stops. This generally happens over the course of 1-3 hours, allowing time for intervention. Naloxone is an opioid antagonist which fits into the receptor, in effect stealing the parking place and preventing opioids from going where they want to go. This restores respiration and prevents death. Naloxone starts to wear off after about 30 minutes and is mostly gone after about 90 minutes. By this time the body has metabolized enough of the opiates that the user is unlikely to stop breathing again. However, in some cases such as after taking a massive dose or long-acting opiates like methadone the person might need another dose of naloxone. Naloxone can help even if opiates are taken with alcohol or other drugs. It has no effect on someone not having an opioid overdose. Resource: Harm Reduction Coalition: Guide to Developing & Managing Overdose Prevention & Take-Home Naloxone Projects 11/10/

30 Someone experiencing opioid overdose needs immediate medical attention and emergency response intervention. The following actions align with emergency response actions for unconscious victims as provided in American Heart Association and American Red Cross training programs. Checking for signs of overdose and responsiveness are the first actions for responders. If they do not respond, rub your knuckles hard up and down their breast bone for 5-10 seconds. This is called a sternal rub and would typically be uncomfortable in someone experiencing overdose who has not yet become unconscious. Ask someone to call 911 and activate your school s emergency response system which for public schools, must include obtaining the AED. Administer naloxone following the steps on the next slides. After administering naloxone, place the victim on their side and monitor. Continue to provide rescue breathing or CPR if needed. Stay with the overdosed person until the ambulance arrives. Maintain your safety by following universal precautions in touching body fluids. If possible, ask a bystander what the person may have injected, ingested, or inhaled or if they have used a patch on their skin, so you can provide this information to EMS. This is especially helpful if the person may have used more than one substance. Notify administration and family and document the use of naloxone in accordance with district policy and procedures. Resources: Overdose Prevention & Reversal Training. Amu Ptah Riojas, MA, Harm Reduction Coordinator, Monique Wright, MEd, Harm Reduction Educator; New York City Department of Health and Mental Hygiene -Bureau of Alcohol and Drug Use Prevention, Care and Treatment American Heart Association: Highlights of the 2010 American Heart Association Guidelines for CPR and ECC American Red Cross Guidelines: Checking an injured or ill adult appears to be unconscious. 30

31 To administer Naloxone the person must exhibit non-responsiveness, shallow/slow or no breathing. Lips and nail beds will typically be bluish. Follow this diagram to determine what to do. 31

32 The naloxone overdose kit should be stored in a secure but accessible location determined in conjunction with the district emergency response plan, which includes AED delivery to the scene of an emergency. One option for placement is to store the naloxone overdose kit inside flap of the AED case. It is important to note that naloxone and the AED are both heat and cold sensitive. Additional information on storage and access is available in the NYSED Opioid Overdose Prevention Guidance Document available on the NYSED website. 32

33 School staff should follow district policy and procedures for reporting the use of naloxone. It will be important to document the location, type of substances used by the victim if known, the status of the person before giving the naloxone, details regarding the administration such as number of vials used and how long it took the person to respond, if CPR was administered, and if the victim survived. Additional guidance is provided in the NYSED Guidance Document on Opioid Overdose Prevention in Schools. Resource: NYSDOH Opioid Prevention Webpage: 33

34 The inventory of naloxone and other overdose supplies should be routinely assessed, with a recommended frequency of once per week, to determine whether there are any discrepancies between documented inventory and actual inventory and to prevent such discrepancies, and make sure the solution in the vial is clear and not discolored. The naloxone vial has an expiration date on the back. Checking this date should be part of any district protocol, similar to checking the AED. The expiration date should be recorded at the time the kit is received and monitored so it is ready for emergency use. New kits should be requested prior to the expiration date or if used even if only one of the naloxone vials is used. Naloxone should be stored in a secure location according to manufacturers recommendations at room temperature, away from light. If the solution is discolored or is not clear, the clinical provider should be informed so that it may be disposed of and replaced. Used atomizers or syringes should be given to EMS personnel or disposed per district policy and procedure. It is important to include information about bloodborne pathogens and safe needle disposal in district guidance. Resource: New York State Department of Health Opioid Overdose Prevention Guidelines for Policies and Procedures, March 21, prevention/programs/guidelines/docs/policies_and_procedures.pdf accessed 6/25/15 34

35 The NYSSHSC has created an Opioid Overdose Prevention Toolkit on our website with a wealth of resources for schools, parents and students. Additional information specific to the role of the school medical director is available on the NYSSHSC School Medical Director Page. Click the blue link to view the page now. 35

36 In 2014, Governor Andrew M. Cuomo launched Combat Heroin, a campaign designed to inform and educate New Yorkers about the risks of heroin and prescription opioid use, the signs of addiction, and the resources available to help. The NYS Office of Alcoholism and Substance Abuse Services (NYOASAS), the NYS Department of Health, and the NYS Office of General Services Media Services Center have worked together to create a multifaceted media campaign which includes an easy to navigate website targeted toward parents, adults, and young people who are seeking help and information concerning heroin and opioid abuse and misuse. The website, noted at the top of this slide includes information about the warning signs of heroin and opioid abuse, a link to OASAS services, listings of treatment providers, and many other resources for schools to use in prevention and training. These resources are free and can be ordered using the form found under resource link on the Combat Heroin website. The website is included in the resources tab in the upper right corner of this presentation. Resource: Combat Heroin Website: v.pdf 36

37 According to the NY Youth Risk Behavior Survey, the percentage of New York State high school students who reported using heroin has more than doubled in recent years. In 2013, there were over 89,000 admissions into treatment facilities for heroin and prescription opioid abuse in NYS. School personnel play a critical role in educating students about substance abuse, addiction and overdose prevention. Recognizing behaviors or symptoms which indicate at-risk students and following district procedures for referral can be critical to reducing potential overdose in the school community. The NYSDOH and OASAS have free resources for classrooms, health offices, parents and students. Some of them are displayed on this slide. Resource: Dear Colleague Letter: NYSDOH, NYSED, NYOASAS (1Youth Risk Behavior Survey, 2005 and 2011). nalandeducationalleaderlettersignedfinal2014.pdf New York State Department of Health (NYSDOH) and New York State Office of Alcoholism and Substance Abuse Services (OASAS) Materials Pertaining to Opioid Overdose Materials for Patients and the Public erials.htm 37

38 Trained responders should know where the overdose kit is stored so they can access it quickly. The kit contains everything needed for response. 38

39 There are two types of kits. One contains nasal naloxone and one contains intramuscular or IM naloxone. You may only administer the type that you have received training for. The nasal overdose kit contains 2 needle-free syringes, 2 nasal atomizers and 2 vials of Naloxone Hydrochloride and 1 set of gloves. It also has instructions of what to do in English and Spanish, alcohol pads and a disposable face shield to use as a barrier to provide rescue breathing. Two sets of naloxone medication are provided as the victim may need a second administration if they do not respond in 3-5 minutes after the initial administration or if EMS is delayed and symptoms return after minutes. Gloves are provided so that responders can maintain universal precautions if there is contact with body fluids. 39

40 Each box in the nasal overdose kit contains a needle-free syringe and a 2 milliliter single use pre-filled vial of naloxone hydrochloride medication solution. 40

41 The steps for administering naloxone are listed on this slide. They will be reviewed step by step in the following slides. Resource: 41

42 Pull or pry the protective caps from both ends of the needle-free syringe. 42

43 Remove the red or purple cap off the glass vial. 43

44 Remove the nasal atomizer (white cone) from its package. Grip the clear plastic wings on the atomizer and gently twist or screw it clockwise on to the top (narrow end) of the syringe. 44

45 Take the naloxone medication vial and place the open end into the open end of the syringe. Thread or screw the naloxone vial onto the syringe by gently twisting it clockwise about 3 half turns or until you feel the rubber stopper catch. Go slowly and if you see any clear medication at the tip STOP. You will notice that the vial has marks on the side. There are a total of 2 milliliters of medicine in the vial. ½ of the total amount or 1 milliliter is used for each nostril. 45

46 Wipe the nose if it is soiled and hold the persons head with one hand, keeping the head tilted backward to prevent the medication from running out of the nose. Place the nasal atomizer in one nostril and push the vial into the syringe until you reach the 1 mark on the vial. Move the atomizer to the other nostril and push the vial to spay the remaining 1 milliliter into the other nostril. If you accidently spray all of the medication into one nostril, the medication will still work. If for some reason you do not have the cone-shaped atomizer in the kit, just place the tip of the syringe near or inside the nostril to administer. 46

47 After naloxone, the person should begin to breathe more normally and it will become easier to wake them. If the person does not respond after 3-5 minutes, administer a 2nd dose as ordered by the medical director. Naloxone only lasts for minutes, so an additional dose may also be needed if EMS has not arrived by that time. The person should be placed on their back on his/her back for any additional naloxone administrations so the naloxone does not run out of their nose. Rapid opiate withdrawal may cause nausea and vomiting. It is important to roll the person to their side to keep their airway clear. This is called the recovery position and is shown on this slide. The hand supports the head and the bent knee supports the body to keep them from rolling onto their stomach. When the person wakes up, explain what happened. They may become combative or upset. When the ambulance arrives, tell them that naloxone has been given. If a victim is not responsive to stimulation, not breathing, and has no pulse after receiving naloxone and rescue breathing, then the victim needs cardiopulmonary resuscitation (CPR) via a trained bystander and the emergency medical system. You will be able to review these steps in action by watching a video at the end of this presentation. The video is also available on the Heroin and Opioid resource page of the NYSSHSC website. Photo: Opioid Overdose Resuscitation Card American Society of Anesthesiologists (ASA) and White House Office of National Drug Control Policy 47

48 Administration of injectable naloxone by a licensed professional follows the same steps in recognizing and responding to an overdose with the only difference being that the naloxone is administered by injection rather than nasally. They are reviewed on this slide. Injectable naloxone comes packaged in single dose flip-top vials with a pop off top. With all formulations of naloxone, it is important to check the expiration date and make sure to keep it from light if it is not stored in a box. Resource: Harm Reduction Coalition:

49 This 5 minute video provides a overview about administration naloxone in schools by Martha Morrissey, Associate in School Nursing, NY State Education Department and Dr. Sharon Stancliff, Medical Director of the Harm Reduction Coalition in New York City. If you have questions about implementing a voluntary Opioid Overdose Prevention Program contact the NYS Education Department Office of Student Support Services at or StudentSupportServices@nysed.gov 49

50 50

51 You are now ready to become an opioid overdose responder for your school or district. 51

52 Push the red button to view the video on assembling the naloxone nasal atomizer. After viewing the video, return to this presentation by clicking next. View the next slide to print your post-test, training skills checklist, and certificate. Button Photo: Tech Happens Blog by TLTC, Buena Vista University and all its posts are licensed under a Creative Commons Attribution-ShareAlike 3.0 Unported License. accessed 7/14/15 52

53 53

54 If you are a non-medical, unlicensed school staff member, you must complete the posttest and training skills checklist to obtain your certificate of completion in Opioid Overdose Prevention. Print out and complete the post-test. Check your answers against the slides in this presentation. The slide which contains the correct information is provided on the post-test. If you have not achieved 100% accuracy, review the training and take the test again. Once you have achieved 100% on the test, take it and the Training Skills Checklist to the designated review person. In most cases this will be a school nurse employed by your school or district. They will review administration of intranasal naloxone and your ability to do it correctly. Upon completion of the skills check, you will receive a certificate of training completion. This certificate is valid for a period of 2 years from the date of the training, however NYSED strongly recommends annual review to maintain proficiency in naloxone administration. Please retain the certificate for your records. School nurses are typically the on-site medical professional and as such may be requested to provide this training and perform the post-test skills check. If you are a registered professional school nurse, please discuss your role in opioid overdose prevention with your district administration. The link to the Post-test, Training Skills Checklist and certificate can be found on the Heroin and Opioid page of the NYSSHSC website. The link is located at the top of this slide. 54

55 55

SUBJECT: Opioid Overdose and Intranasal Naloxone Training for Law Enforcement: Train the Trainer Session: Queens County October 17, 2014

SUBJECT: Opioid Overdose and Intranasal Naloxone Training for Law Enforcement: Train the Trainer Session: Queens County October 17, 2014 ANDREW M. CUOMO GOVERNOR STATE OF NEW YORK DIVISION OF CRIMINAL JUSTICE SERVICES Alfred E. Smith Office Building 80 South Swan Street Albany, New York 12210 http://criminaljustice.ny.gov MICHAEL C. GREEN

More information

Braintree Public Schools

Braintree Public Schools Braintree Public Schools Policy and Procedures for School Nurse, Athletic Director and Athletic Trainer Management of Potential Life Threatening Opioid Overdose Program Policy In order to recognize and

More information

Opiate Overdose Treatment: Naloxone Training Protocol

Opiate Overdose Treatment: Naloxone Training Protocol OREGON STATE PUBLIC HEALTH DIVISION EMS & Trauma Systems Kate Brown, Governor September 22, 2016 For more information, contact David Lehrfeld, MD, Medical Director, EMS & Trauma Systems: (971) 673-0520

More information

Naloxone HCI 4 mg/0.1. nostril. Repeat after 3 minutes if minimal or no

Naloxone HCI 4 mg/0.1. nostril. Repeat after 3 minutes if minimal or no THE SOUTH CAROLINA BOARD OF MEDICAL EXAMINERS AND THE SOUTH CAROLINA BOARD OF PHARMACY S JOINT PROTOCOL TO INITIATE DISPENSING OF NALOXONE HCI WITHOUT A PRESCRIPTION This joint protocol authorizes any

More information

Drug Overdose Prevention Program (DOPP)

Drug Overdose Prevention Program (DOPP) Drug Overdose Prevention Program (DOPP) GUIDELINES FOR IMPLEMENTATION [Type a quote from the documen T or the s ummary of an interesting p oint. You can position the text box anywhere in the document.

More information

Revised 16 February, of 7

Revised 16 February, of 7 341 State Street Suite G Madison, WI 53703 ph: (608) 251 4454 f: (608) 251 3853 6333 University Avenue, Middleton WI 53562 ph: (608) 310 5389 f: (608) 285 9603 INTRANASAL OR INTRAMUSCULAR NALOXONE PROTOCOL:

More information

Campus Narcan Project OPIOID OVERDOSE FIRST RESPONDER TRAINING

Campus Narcan Project OPIOID OVERDOSE FIRST RESPONDER TRAINING Campus Narcan Project OPIOID OVERDOSE FIRST RESPONDER TRAINING Opioid Epidemic Prescription Opiods Can be prescribed by doctors to treat moderate to severe pain, but can also have serious risks and side

More information

Calvert County Health Department Overdose Education and Naloxone Training

Calvert County Health Department Overdose Education and Naloxone Training Calvert County Health Department Overdose Education and Naloxone Training Maryland Overdose Response Program January 2015 Behavioral Health Administration Department of Health & Mental Hygiene dhmh.naloxone@maryland.gov

More information

Law Enforcement Naloxone Training Florida Department of Children and Families. Office of Substance Abuse and Mental Health

Law Enforcement Naloxone Training Florida Department of Children and Families. Office of Substance Abuse and Mental Health Protecting, Leading, Uniting Since 1893 Law Enforcement Naloxone Training Florida Department of Children and Families Office of Substance Abuse and Mental Health 1. Learn how to recognize and respond to

More information

Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals

Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals Clint Ross, PharmD, BCPP Clinical Pharmacy Specialist Psychiatry Residency Program Director Psychiatric Pharmacy Medical University

More information

NALOXONE AND OVERDOSE PREVENTION EDUCATION PROGRAM OF RHODE ISLAND

NALOXONE AND OVERDOSE PREVENTION EDUCATION PROGRAM OF RHODE ISLAND NALOXONE AND OVERDOSE PREVENTION EDUCATION PROGRAM OF RHODE ISLAND Law Enforcement and Public Safety!!!!!!! Ariel Engelman NOPE-RI Coordinator 1 Opioids and Overdose in Rhode Island 2 Opioids and Overdose

More information

Naloxone Non-Patient Specific Prescription and Pharmacist Dispensing Protocol, New York City

Naloxone Non-Patient Specific Prescription and Pharmacist Dispensing Protocol, New York City Section 1: Purpose Naloxone Non-Patient Specific Prescription and Pharmacist Dispensing Protocol, New York City As some of health care s most accessible practitioners, pharmacists are uniquely positioned

More information

Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative

Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative Background: In September 2015, Illinois passed a new law, PA99-0480, expanding access to the opioid

More information

Transcript for Overdose Responder Training: Adapted from NJ Department of Human Services/Division of Mental Health and Addiction Services

Transcript for Overdose Responder Training: Adapted from NJ Department of Human Services/Division of Mental Health and Addiction Services Transcript for Overdose Responder Training: Adapted from NJ Department of Human Services/Division of Mental Health and Addiction Services #1 TITLE SLIDE #2 INTRODUCTION AND PURPOSE Welcome to Overdose

More information

NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION

NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION Chapter NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION EFFECTIVE: Policy REVISED: 4/13/9 draft NALOXONE DISTRIBUTION POLICY I. PURPOSE: This New Mexico Department of Health (NMDOH)

More information

NALOXONE (NARCAN) POLICY

NALOXONE (NARCAN) POLICY POLICE DEPARTMENT NALOXONE (NARCAN) POLICY GENERAL ORDER NO. 2015-65 1.0 Policy This Order contains the following numbered sections: 2.0 Personnel Affected 3.0 Purpose 1.0 Policy 2.0 Personnel Affected

More information

NALOXONE LEARNING ABOUT NALOXONE COULD SAVE A LIFE

NALOXONE LEARNING ABOUT NALOXONE COULD SAVE A LIFE NALOXONE LEARNING ABOUT NALOXONE COULD SAVE A LIFE WHAT IT IS WHAT IT IS NARCAN (naloxone HCl) Nasal Spray is the first and only FDA-approved nasal form of naloxone for the emergency treatment of a known

More information

Naloxone Standing Order for Opioid Overdose

Naloxone Standing Order for Opioid Overdose Naloxone Standing Order for Opioid Overdose By: Christine Trusky, PharmD Candidate 2016, Wilkes University Continuing Education Activity Details: Activity Type: Knowledge-based Target Audience: Pharmacists

More information

Evaluations. Viewer Call-In. Guest Speakers. What s New in AIDS/HIV? Phone: Fax: Thank You to our Sponsors

Evaluations. Viewer Call-In. Guest Speakers. What s New in AIDS/HIV? Phone: Fax: Thank You to our Sponsors What s New in AIDS/HIV? December 16, 2010 Guest Speakers Dr. Amneris Luque Director, AIDS Center at Strong Memorial Hospital Alma Candelas Director, Division of HIV Prevention, AIDS Institute Dan O Connell

More information

Opioid Overdose Prevention for Law Enforcement and First Responders. Sponsored by the NC Office of EMS

Opioid Overdose Prevention for Law Enforcement and First Responders. Sponsored by the NC Office of EMS Opioid Overdose Prevention for Law Enforcement and First Responders Sponsored by the NC Office of EMS Overview The goal of this presentation is to help inform the public safety community of North Carolina

More information

NARCAN: THE HISTORY, APPLICATIONS AND FUTURE

NARCAN: THE HISTORY, APPLICATIONS AND FUTURE NARCAN: THE HISTORY, APPLICATIONS AND FUTURE TABLE OF CONTENTS 3 Intro 4 What is Naloxone? 8 How Naloxone is Administered 12 Where to Find Narcan in California The United States accounts for about five

More information

Opioid Harm Reduction

Opioid Harm Reduction Opioid Harm Reduction Lucas G. Hill, PharmD Clinical Assistant Professor, The University of Texas at Austin College of Pharmacy Clinical Pharmacist, CommUnityCare FQHCs Director, Operation Naloxone Mark

More information

Pennsylvania DEPARTMENT OF HEALTH

Pennsylvania DEPARTMENT OF HEALTH Pennsylvania DEPARTMENT OF HEALTH Updated: 01/10/2018 XI. XII. KEY INFORMATION 1. If you believe, someone is experiencing an opioid overdose, call 911! 2. Remain with the person until first responders

More information

OVERDOSE IN UTAH PREVENTION AND RESPONSE. Meghan Balough, MPH Heather Bush, B.S. Suicide Conference October 6, 2017

OVERDOSE IN UTAH PREVENTION AND RESPONSE. Meghan Balough, MPH Heather Bush, B.S. Suicide Conference October 6, 2017 OVERDOSE IN UTAH PREVENTION AND RESPONSE Meghan Balough, MPH Heather Bush, B.S. Suicide Conference October 6, 2017 Questions How many people have known someone who has experienced an overdose? How many

More information

Naloxone Administration Training

Naloxone Administration Training Naloxone Administration Training Welcome! Welcome to the online training for naloxone administration The Presenter Dr. Joe Parks, Medical Director, Distinguished Professor, Missouri Institute for Mental

More information

Be it enacted by the People of the State of Illinois,

Be it enacted by the People of the State of Illinois, AN ACT concerning education. Be it enacted by the People of the State of Illinois, represented in the General Assembly: Section 5. The School Code is amended by changing Section 22-30 as follows: (105

More information

Anyone Can Become Addicted. Anyone.

Anyone Can Become Addicted. Anyone. Anyone Can Become Addicted. Anyone. PAStop.org Family Toolkit Seeking Drug Abuse Treatment: Know What to Ask Trying to identify the right treatment programs for a loved one can be a difficult process.

More information

Take Home Naloxone elearning Module Script

Take Home Naloxone elearning Module Script elearning Module Script Slide 1-3 Review the outline and the plan for the presentation. Slide 4 We do accept the cynicism of this poster. Slide 5 Read from the slide the definition of Harm Reduction Slide

More information

Dutchess County Substance Abuse Prevention Initiative

Dutchess County Substance Abuse Prevention Initiative Dutchess County Substance Abuse Prevention Initiative Prevention Agenda Priority Promote Mental Health and Prevent Substance Abuse Latham, NY Wednesday, November 12, 2014 Background Justification: a) Mortality

More information

First Responder Naloxone Grant Webinar

First Responder Naloxone Grant Webinar First Responder Naloxone Grant Webinar December 22, 2014 Sarah Ruiz, MSW, Project Manager Naloxone Pilot Program, Massachusetts Department of Public Health Dr. Alexander Walley, MD, MSc, Assistant Professor

More information

ADMINISTRATION OF NALOXONE HCI REVISED: 10/17

ADMINISTRATION OF NALOXONE HCI REVISED: 10/17 POLICY 513 ADMINISTRATION OF NALOXONE HCI REVISED: 10/17 RELATED POLICIES: CFA STANDARDS: 14.14 REVIEWED: AS NEEDED A. PURPOSE The purpose of this policy is to establish guidelines and procedures governing

More information

Welcome to the Opioid Overdose Prevention Project

Welcome to the Opioid Overdose Prevention Project Welcome to the Opioid Overdose Prevention Project Narcan Training TODAY S OBJECTIVES Define drug addiction Identify symptoms of addiction Treatment options including support for family members How to recognize

More information

Prescription Opioids

Prescription Opioids What are prescription opioids? Prescription Opioids Opioids are a class of drugs naturally found in the opium poppy plant. Some prescription opioids are made from the plant directly, and others are made

More information

1/23/2015. Disclosure. Overview. A National Response to a Public Health Crisis Opioid Overdose and the Changing Spectrum of Care

1/23/2015. Disclosure. Overview. A National Response to a Public Health Crisis Opioid Overdose and the Changing Spectrum of Care A National Response to a Public Health Crisis Opioid Overdose and the Changing Spectrum of Care Michael W. Dailey, MD FACEP Chief, Division of Prehospital and Operational Medicine Associate Professor of

More information

Naloxone: Preventing Opioid Overdose in the Community. Sharon Stancliff, MD Medical Director Harm Reduction Coalition

Naloxone: Preventing Opioid Overdose in the Community. Sharon Stancliff, MD Medical Director Harm Reduction Coalition Naloxone: Preventing Opioid Overdose in the Community Sharon Stancliff, MD Medical Director Harm Reduction Coalition DISCLOSURES Sharon Stancliff MD has nothing to disclose LEARNING OBJECTIVES 1. Discuss

More information

PREVENTING OPIATE OVERDOSES IN SCHOOLS. Head 2 Toe 2017 April 20, 2017 Winona Stoltzfus BSN, MD, School Health Officer and Acting RHO SE Region

PREVENTING OPIATE OVERDOSES IN SCHOOLS. Head 2 Toe 2017 April 20, 2017 Winona Stoltzfus BSN, MD, School Health Officer and Acting RHO SE Region PREVENTING OPIATE OVERDOSES IN SCHOOLS Head 2 Toe 2017 April 20, 2017 Winona Stoltzfus BSN, MD, School Health Officer and Acting RHO SE Region WHY IS THIS EVEN A QUESTION FOR SCHOOLS? In 2014, 467,000

More information

CRITICAL POLICY REFERENCE MANUAL FILE CODE: X Monitored X Mandated Sample Policy X Other Reasons

CRITICAL POLICY REFERENCE MANUAL FILE CODE: X Monitored X Mandated Sample Policy X Other Reasons CRITICAL POLICY REFERENCE MANUAL FILE CODE: 5141.21 X Monitored X Mandated Sample Policy X Other Reasons ADMINISTERING MEDICATION The board shall not be responsible for the diagnosis and treatment of student

More information

The Missouri Opioid-Heroin Overdose Prevention and Education (MO-HOPE) Project Mission: to reduce opioid overdose deaths in Missouri through expanded

The Missouri Opioid-Heroin Overdose Prevention and Education (MO-HOPE) Project Mission: to reduce opioid overdose deaths in Missouri through expanded The Missouri Opioid-Heroin Overdose Prevention and Education (MO-HOPE) Project Mission: to reduce opioid overdose deaths in Missouri through expanded access to naloxone, overdose education, prevention,

More information

How to Prevent an Opioid Overdose

How to Prevent an Opioid Overdose How to Prevent an Opioid Overdose MEDICAL CARE PROVIDERS: Providers can help reduce the likelihood of an opioid overdose by identifying patients who are at increased risk of opioid-induced respiratory

More information

Overdose Prevention, Recognition & Response Education Train-the-Trainer

Overdose Prevention, Recognition & Response Education Train-the-Trainer Overdose Prevention, Recognition & Response Education Train-the-Trainer Bernie Lieving, MSW Overdose Prevention Education Coordinator Santa Fe Prevention Alliance & Office of Substance Abuse Prevention

More information

DISPENSING OR SELLING NALOXONE. Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug.

DISPENSING OR SELLING NALOXONE. Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug. DISPENSING OR SELLING NALOXONE Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug. UPDATED ON: April 21, 2017 Purpose The intent of this document is to provide

More information

NALOXONE CAN BE A LIFESAVER

NALOXONE CAN BE A LIFESAVER NALOXONE 1 CAN BE A LIFESAVER Naloxone is a drug which can temporarily reverse the effects of opioid (heroin/methadone) overdose. In an overdose state, it can be a lifesaver 2 3 what to do IF SOMEONE HAS

More information

ORC Why Narcan? Things to know about Narcan. Things to know about Narcan 4/16/2018

ORC Why Narcan? Things to know about Narcan. Things to know about Narcan 4/16/2018 ORC 2925.61 Under the authority of Ohio Revised Code section 2925.61, peace officers that have been approved by their department to carry and administer (also known as naloxone), will carry the kits in

More information

Role of the Pharmacist: Naloxone Training. Kathleen Besinque, Pharm.D.,MSEd., FASHP, FCPhA Loma Linda University School of Pharmacy

Role of the Pharmacist: Naloxone Training. Kathleen Besinque, Pharm.D.,MSEd., FASHP, FCPhA Loma Linda University School of Pharmacy Role of the Pharmacist: Naloxone Training Kathleen Besinque, Pharm.D.,MSEd., FASHP, FCPhA Loma Linda University School of Pharmacy Disclosure Kathleen Besinque Nothing to disclose. Objectives: After attending

More information

NASSAU REGIONAL EMERGENCY MEDICAL ADVISORY COMMITTEE

NASSAU REGIONAL EMERGENCY MEDICAL ADVISORY COMMITTEE NASSAU REGIONAL EMERGENCY MEDICAL ADVISORY COMMITTEE 2201 Hempstead Turnpike, Bin 78 Phone: 516-542-0025 East Meadow, NY 11554-1859 FAX: 516-542-0049 Website: www.nassauems.org To: All Emergency Medical

More information

ADMINISTRATIVE REQUIREMENT MANUAL EFFECTIVE DATE

ADMINISTRATIVE REQUIREMENT MANUAL EFFECTIVE DATE PURPOSE: I. To establish the minimum requirements for a first responder training course in first aid, which all first responders must take, in order to meet the requirements of M.G.L. c. 111, 201 and 105

More information

Strategies to Manage The Opioid Crisis

Strategies to Manage The Opioid Crisis Strategies to Manage The Opioid Crisis Matt Feehery, LCDC Senior Vice President & CEO PaRC (Prevention & Recovery Center) Behavioral Health Services February 1, 2018 A Pill for Your Pain But my doctor

More information

Prepublication Requirements

Prepublication Requirements Issued Prepublication Requirements The Joint Commission has approved the following revisions for prepublication. While revised requirements are published in the semiannual updates to the print manuals

More information

Dispensing and administration of emergency opioid antagonist without a

Dispensing and administration of emergency opioid antagonist without a 68-7-23. Dispensing and administration of emergency opioid antagonist without a prescription. (a) A pharmacist may dispense an FDA-approved emergency opioid antagonist and the necessary medical supplies

More information

Naloxone in Schools. Training for School Staff

Naloxone in Schools. Training for School Staff Naloxone in Schools Training for School Staff Objectives Learn the signs and symptoms of opioid drug overdose Have the skills to administer naloxone Review the use of naloxone protocol in responding to

More information

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016 1 Opioid Abuse in Iowa Rx to Heroin Iowa Governor s Office of Drug Control Policy January 2016 Why Is This Important? 2 3 National Rx Painkiller Trends CDC, 2013 4 National Rx-Heroin Trends NIH, 2015 5

More information

NALOXONE RISK ASSESSMENT

NALOXONE RISK ASSESSMENT NALOXONE RISK ASSESSMENT Intended audience: Non-public sector organizations. Introduction: BC is currently experiencing a public health emergency related to the unprecedented increase in opioid overdoses

More information

Pharmacist Learning Objectives

Pharmacist Learning Objectives Opioid Overdose Education and Naloxone Distribution Keith Thornell, Pharm.D. Clinical Pharmacist Co-Occurring Disorders Pain Clinic NM Veterans Affairs Health Care System richard.thornell@va.gov 1 Pharmacist

More information

Opioids and Overdose 2017

Opioids and Overdose 2017 Opioids and Overdose 2017 This presentation is an introduction to: 1. Opioids, overdose and naloxone 2. How you can help A partnership of: Opioids A class of drugs taken for pain relief or euphoria. Prescribed

More information

Skills and Knowledge on Overdose Prevention. Bill Matthews, RPA-C Bethany Medley, MSW Bruce Trigg, MD

Skills and Knowledge on Overdose Prevention. Bill Matthews, RPA-C Bethany Medley, MSW Bruce Trigg, MD Skills and Knowledge on Overdose Prevention Bill Matthews, RPA-C Bethany Medley, MSW Bruce Trigg, MD Harm Reduction Coalition POLICY & ADVOCACY TRAINING & CAPACITY BUILDING OVERDOSE PREVENTION & ADVOCACY

More information

1 HB By Representative Williams (JD) 4 RFD: Health. 5 First Read: 09-JAN-18 6 PFD: 11/28/2017. Page 0

1 HB By Representative Williams (JD) 4 RFD: Health. 5 First Read: 09-JAN-18 6 PFD: 11/28/2017. Page 0 1 HB37 2 188862-1 3 By Representative Williams (JD) 4 RFD: Health 5 First Read: 09-JAN-18 6 PFD: 11/28/2017 Page 0 1 188862-1:n:11/16/2017:PMG/tj LSA2017-3516 2 3 4 5 6 7 8 SYNOPSIS: This bill would establish

More information

3/19/18. Background. School Substance Use Problem: Naloxone and How It Will Be Implemented in Schools. Background

3/19/18. Background. School Substance Use Problem: Naloxone and How It Will Be Implemented in Schools. Background School Substance Use Problem: Naloxone and How It Will Be Implemented in Schools Rodrick J. Marriott, PharmD Director, Drug Control Division Background Background Overdose deaths involving prescription

More information

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS Charles W. Morgan, MD, DFASAM, FAAFP Medical Director New York State Office of Alcoholism and Substance Abuse Services February

More information

A Bill Regular Session, 2015 SENATE BILL 880

A Bill Regular Session, 2015 SENATE BILL 880 Stricken language would be deleted from and underlined language would be added to present law. Act of the Regular Session 0 State of Arkansas 0th General Assembly As Engrossed: S// H// A Bill Regular Session,

More information

Naloxone Statewide Standing Order. Cheryl A. Viracola, PharmD Pharmacy Programs Manager, Community Care of Wake and Johnston Counties

Naloxone Statewide Standing Order. Cheryl A. Viracola, PharmD Pharmacy Programs Manager, Community Care of Wake and Johnston Counties Naloxone Statewide Standing Order Cheryl A. Viracola, PharmD Pharmacy Programs Manager, Community Care of Wake and Johnston Counties Objectives Review the US & NC trends on opioid overdose Understand key

More information

Temple University Beasley School of Law. Project on Harm Reduction in the Health Care System

Temple University Beasley School of Law. Project on Harm Reduction in the Health Care System Temple University Beasley School of Law Project on Harm Reduction in the Health Care System DATE: January 8, 2008 MEMORANDUM RE: The legal requirements for operating an Opioid Antagonist Administration

More information

Grampian Naloxone Programme Pre-reading Materials (Adapted from materials supplied with the kind permission of the Scottish Drugs Forum)

Grampian Naloxone Programme Pre-reading Materials (Adapted from materials supplied with the kind permission of the Scottish Drugs Forum) Grampian Naloxone Programme Pre-reading Materials (Adapted from materials supplied with the kind permission of the Scottish Drugs Forum) This presentation aims to refresh knowledge on the causes, risk

More information

TO YOUR PHARMACIST TOOLKIT. A Guide to Help Utah Pharmacists Talk to Customers About Prescription Opioids

TO YOUR PHARMACIST TOOLKIT. A Guide to Help Utah Pharmacists Talk to Customers About Prescription Opioids TALK TO YOUR PHARMACIST TOOLKIT A Guide to Help Utah Pharmacists Talk to Customers About Prescription Opioids Acknowledgements This report was made possible by the following individuals and agencies: Stephanie

More information

OPIOID WORKGROUP LEADERSHIP TEAM

OPIOID WORKGROUP LEADERSHIP TEAM OPIOID WORKGROUP LEADERSHIP TEAM Community-wide Action Plan and Call to Action This brief summary of the Opioid Action Plan presented to the Skagit County Board of Health on December 13, 2016 provides

More information

Reducing opioid overdose mortality: role of communityadministered

Reducing opioid overdose mortality: role of communityadministered Reducing opioid overdose mortality: role of communityadministered naloxone Vennus Ballen, MD, MPH; Lara Maldjian, MPH New York City Department of Health and Mental Hygiene Clinical Director s Network (CDN)

More information

The Solution. A multi-faceted approach to overdose prevention is required. A comprehensive array of efforts are underway in Oklahoma, including:

The Solution. A multi-faceted approach to overdose prevention is required. A comprehensive array of efforts are underway in Oklahoma, including: Saves Lives The Solution A multi-faceted approach to overdose prevention is required. A comprehensive array of efforts are underway in Oklahoma, including: PREVENTION & EDUCATION MONITORING & DIVERSION

More information

H NDS-ONHealth. Prescription Drug Abuse. Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher.

H NDS-ONHealth. Prescription Drug Abuse. Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher. H NDS-ONHealth Health Wave Newsletter, October 2013 Visit us on our website at www.healthwaveinc.com Drug overdose death rates in the United States have more than tripled since 1990 and have never been

More information

SULLIVAN COUNTY Drug Abuse Prevention Task Force

SULLIVAN COUNTY Drug Abuse Prevention Task Force SULLIVAN COUNTY Drug Abuse Prevention Task Force Joseph A. Todora LMSW, Commissioner Sullivan County Division of Health ans Family Servies 17 Community Lane Liberty, NY 12754 MISSION: The mission of the

More information

Community Pharmacy Distribution of Naloxone

Community Pharmacy Distribution of Naloxone Community Pharmacy Distribution of Naloxone College of Pharmacists of BC BC Centre for Disease Control Harm Reduction Program Sponsored in part by the BC Ministry of Health What is Naloxone? Naloxone is

More information

Drug Class Review: Opioid Reversal Agents

Drug Class Review: Opioid Reversal Agents Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Combating the Opiate Crisis in Ohio

Combating the Opiate Crisis in Ohio Combating the Opiate Crisis in Ohio In 2011, Gov. John R. Kasich announced the establishment of the Governor s Cabinet Opiate Action Team to fight opiate abuse in Ohio. Ohio is combating drug abuse through

More information

Drug Prevention: Health & Opioid Prevention Education (HOPE) Curriculum

Drug Prevention: Health & Opioid Prevention Education (HOPE) Curriculum Drug Prevention: Health & Opioid Prevention Education (HOPE) Curriculum Ohio SOPHE Health Educators Institute October 27, 2017 Kevin Lorson HOPECurriculum@wright.edu Today s Goals: 1. Describe prevention

More information

NALOXONE CAN BE A LIFESAVER

NALOXONE CAN BE A LIFESAVER NALOXONE 1 CAN BE A LIFESAVER Naloxone is a drug which can temporarily reverse the effects of opioid (heroin/methadone) overdose. In an overdose state, it can be a lifesaver 2 3 what to do IF SOMEONE HAS

More information

COMBATING THE OPIATE CRISIS IN OHIO THROUGH COMPREHENSIVE RESPONSE 2018 HOUSING OHIO CONFERENCE APRIL 9 TH, Objectives: Key Terms

COMBATING THE OPIATE CRISIS IN OHIO THROUGH COMPREHENSIVE RESPONSE 2018 HOUSING OHIO CONFERENCE APRIL 9 TH, Objectives: Key Terms COMBATING THE OPIATE CRISIS IN OHIO THROUGH COMPREHENSIVE RESPONSE 2018 HOUSING OHIO CONFERENCE APRIL 9 TH, 2018 2 Objectives: qreview names of different types of opioids qidentify the signs and symptoms

More information

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Nurse Practitioner Council New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) Peter Ryba, PharmD PMP Director

More information

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation. Pharmacy Law 2016 Ronda H. Lacey, J.D., M.S. Pharm Disclosure Statement I have no conflicts of interest to disclose related to this presentation. Objectives At the conclusion of this continuing education

More information

PROPOSED AMENDMENTS TO HOUSE BILL 3440

PROPOSED AMENDMENTS TO HOUSE BILL 3440 HB 0- (LC ) // (MBM/ps) Requested by Representative WILLIAMSON PROPOSED AMENDMENTS TO HOUSE BILL 0 1 On page 1 of the printed bill, line, delete 1A. and. Delete lines through and pages through and insert:

More information

Sierra Sacramento Valley EMS Agency

Sierra Sacramento Valley EMS Agency Sierra Sacramento Valley EMS Agency BLS IN NALOXONE ADMINISTRATION OPTIONAL SKILL (UPDATED 06/2017) Acknowledgement: Siskiyou County SO - source of some slide content In order for PSFA, EMR or EMT personnel

More information

There are no financial or other pertinent conflicts of interest to disclose. Learning Objectives: Key Questions To Ask 10/4/2014

There are no financial or other pertinent conflicts of interest to disclose. Learning Objectives: Key Questions To Ask 10/4/2014 Maintaining Patient Safety When Chronic Opioid Therapy Is Prescribed P. David Pacheco, Ph.C, PA-C, CAAAPM Pain Medication Management Specialist Southwest Interventional Pain Specialists, PC 4700 Jefferson

More information

Prescription Drug Abuse National Perspective

Prescription Drug Abuse National Perspective Prescription Drug Abuse National Perspective Timothy P. Condon, Ph.D. Science Policy Advisor Office of the Director White House Office of National Drug Control Policy Commonly Abused Prescription Drugs

More information

Overdose Prevention: Empowering School Personnel & Families

Overdose Prevention: Empowering School Personnel & Families Overdose Prevention: Empowering School Personnel & Families Christopher Welsh M.D. University of Maryland School of Medicine NCADD-Maryland Scientific Advisory Committee INITIATION OF DRUG USE >12 Y.O.(2013;

More information

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q) Performance of North Carolina's System for Monitoring Prescription Drug Abuse Session Law 2015-241, Section 12F.16.(q) Report to the Joint Legislative Oversight Committee on Health and Human Services and

More information

Naloxone Information for Community Pharmacies in Georgia: What You Need to Know

Naloxone Information for Community Pharmacies in Georgia: What You Need to Know Naloxone Information for Community Pharmacies in Georgia: What You Need to Know Your pharmacy may start receiving an increased volume of prescriptions for naloxone (Narcan ) due to legal changes in 2014.

More information

R ADMINISTERING AN OPIOID ANTIDOTE. B. Acquisition, Maintenance, Accessibility, and Documentation of an Opioid Antidote

R ADMINISTERING AN OPIOID ANTIDOTE. B. Acquisition, Maintenance, Accessibility, and Documentation of an Opioid Antidote A. Definitions R5330.04/Page 1 of 5 R5330.04 ADINISTERING AN OPIOID ANTIDOTE 1. Opioid antidote means any drug, regardless of dosage amount or method of administration, which has been approved by the United

More information

The Opioid Crisis URBAN FIRE FORUM SEPTEMBER 20-22, 2017

The Opioid Crisis URBAN FIRE FORUM SEPTEMBER 20-22, 2017 The Opioid Crisis URBAN FIRE FORUM SEPTEMBER 20-22, 2017 Every day in the United States, 144 people die as a result of an opioid overdose. Prescription drug abuse is the fastest growing drug problem in

More information

Instructions for Use. For use with. 10 mg vial

Instructions for Use. For use with. 10 mg vial Instructions for Use For use with 10 mg vial Table of Contents Parts of the ZOMA-Jet 10... 1 Supplies you will need to mix a ZOMACTON 10 mg Vial... 2 Mix a ZOMACTON 10 mg vial... 3 Reset the ZOMA-Jet 10...

More information

Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary

Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon 2016 Executive Summary 20.8 million people in the United States have a substance use disorder (not limited to opioids), equivalent

More information

ASSEMBLY, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED MAY 15, 2014

ASSEMBLY, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED MAY 15, 2014 ASSEMBLY, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED MAY, 0 Sponsored by: Assemblyman RONALD S. DANCER District (Burlington, Middlesex, Monmouth and Ocean) Assemblyman HERB CONAWAY, JR. District

More information

Naloxone and Combating the Opioid Epidemic

Naloxone and Combating the Opioid Epidemic Objectives Naloxone and Combating the Opioid Epidemic Jeff Jacobson PharmD Southpointe Pharmacy Discuss the current opioid crisis Define the role of Naloxone in opioid overdose Analyze the barriers to

More information

2/20/2017 NALOXONE PRESCRIPTIONS FOR OVERDOSE: OUTSIDE OF MISUSE AND ABUSE DISCLOSURES LEARNING OBJECTIVES

2/20/2017 NALOXONE PRESCRIPTIONS FOR OVERDOSE: OUTSIDE OF MISUSE AND ABUSE DISCLOSURES LEARNING OBJECTIVES NALOXONE PRESCRIPTIONS FOR OVERDOSE: OUTSIDE OF MISUSE AND ABUSE Brett Badgley Snodgrass FNP-C, CPE, FACPP, FAANP Consultant/Independent Contractor: McNeil Pharmaceuticals, Purdue Pharmaceuticals Speaker's

More information

Michael M. Miller, MD, FASAM, FAPA

Michael M. Miller, MD, FASAM, FAPA Michael M. Miller, MD, FASAM, FAPA mmiller@rogershospital.org Medical Director, Herrington Recovery Center (HRC) Rogers Memorial Hospital Oconomowoc, Wisconsin Vice Speaker Wisconsin Medical Society Clinical

More information

White Paper on. Prescription Drug Abuse

White Paper on. Prescription Drug Abuse White Paper on Prescription Drug Abuse October 22, 2014 Table of Contents: I. Introduction II. Scope of the Problem III. Most Common Drugs Involved in Overdoses IV. Efforts in Tennessee V. Prescription

More information

Opioids - Fentanyl - Naloxone. Public Health Nurse

Opioids - Fentanyl - Naloxone. Public Health Nurse Opioids - Fentanyl - Naloxone Public Health Nurse What are Opioids? Opioids are a family of drugs that treat pain and can cause sleepiness. Prescription (legal) Opioids fall into 3 main categories: 1.

More information

OVERDOSE PREVENTION AND EDUCATION OVERDOSE MANAGEMENT

OVERDOSE PREVENTION AND EDUCATION OVERDOSE MANAGEMENT OVERDOSE PREVENTION AND EDUCATION OVERDOSE MANAGEMENT 1 OBJECTIVES Discuss basics of opioid overdose epidemiology and physiology To share accurate information about overdose prevention and education including

More information

The Challenge of Treating Pain

The Challenge of Treating Pain FDA Charge to the Committee: FDA Opioid Action Plan and Incorporating the Broader Public Health Impact into the Formal Risk-Benefit Assessment for Opioids Robert M. Califf, MD Commissioner of Food and

More information

Prescription Drug Abuse and Heroin: Impact on Oregon s Youth and Young Adults

Prescription Drug Abuse and Heroin: Impact on Oregon s Youth and Young Adults North Coast Opioid Summit Prescription Drug Abuse and Heroin: Impact on Oregon s Youth and Young Adults April 28, 2016 The Oregon Epidemic Oregon ranks #2 in Non-Medical Use of Opioids, 5% of population

More information

Opioid Overdose: Risks, Clinical Features, Treatment, and Reduction of Negative Consequences

Opioid Overdose: Risks, Clinical Features, Treatment, and Reduction of Negative Consequences Opioid Overdose: Risks, Clinical Features, Treatment, and Reduction of Negative Consequences Joji Suzuki, MD Assistant Professor of Psychiatry Harvard Medical School Director, Division of Addiction Psychiatry

More information

Managing Allergies and Anaphylaxis at School: Training for School Personnel

Managing Allergies and Anaphylaxis at School: Training for School Personnel Managing Allergies and Anaphylaxis at School: Training for School Personnel Recognizing Severe Allergic Response Use of Epinephrine Auto-Injectors The resources for this presentation were created by the

More information

Presentation at National Academies of Sciences Engineering Medicine

Presentation at National Academies of Sciences Engineering Medicine FOCUSED ON ADDICTION Presentation at National Academies of Sciences Engineering Medicine 11 th October 2017 COI statement Full time employee of Opiant Pharmaceuticals Inc. Shareholder of Opiant Pharmaceuticals

More information